Cerrone SA, Trindade AJ. Advanced imaging in surveillance of Barrett’s esophagus: Is the juice worth the squeeze? World J Gastroenterol 2019; 25(25): 3108-3115 [PMID: 31333304 DOI: 10.3748/wjg.v25.i25.3108]
Corresponding Author of This Article
Arvind J Trindade, MD, Director of Endoscopy, Division of Gastroenterology, Long Island Jewish Medical Center, Associate Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, 270-05 76th Avenue, New Hyde Park, NY 11040, United States. arvind.trindade@gmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Opinion Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jul 7, 2019; 25(25): 3108-3115 Published online Jul 7, 2019. doi: 10.3748/wjg.v25.i25.3108
Advanced imaging in surveillance of Barrett’s esophagus: Is the juice worth the squeeze?
Sara A Cerrone, Arvind J Trindade
Sara A Cerrone, Arvind J Trindade, Division of Gastroenterology, Long Island Jewish Medical Center, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, New Hyde Park, NY 11040, United States
Author contributions: All the authors contributed to conception and design; analysis and interpretation of the data; drafting of the article; critical revision of the article for important intellectual content; and final approval of the article.
Conflict-of-interest statement: The authors have declared no conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Arvind J Trindade, MD, Director of Endoscopy, Division of Gastroenterology, Long Island Jewish Medical Center, Associate Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, 270-05 76th Avenue, New Hyde Park, NY 11040, United States. arvind.trindade@gmail.com
Telephone: +1-718-4707281 Fax: +1-718-4705509
Received: February 18, 2019 Peer-review started: February 18, 2019 First decision: April 30, 2019 Revised: May 8, 2019 Accepted: May 18, 2019 Article in press: May 18, 2019 Published online: July 7, 2019 Processing time: 138 Days and 5.9 Hours
Abstract
Esophageal cancer is on the rise. The known precursor lesion is Barrett’s esophagus (BE). Patients with dysplasia are at higher risk of developing esophageal cancer. Currently the gold standard for surveillance endoscopy involves taking targeted biopsies of abnormal areas as well as random biopsies every 1-2 cm of the length of the Barrett’s. Unfortunately studies have shown that this surveillance can miss dysplasia and cancer. Advanced imaging technologies have been developed that may help detect dysplasia in BE. This opinion review discusses advanced imaging in BE surveillance endoscopy and its utility in clinical practice.
Core tip: Barrett’s esophagus (BE) is a precursor of esophageal cancer, the incidence of which is on the rise worldwide. Advanced imaging in BE includes dye chromoendoscopy, electronic chromoendoscopy narrow band imaging (NBI), confocal laser endomicroscopy and volumetric laser endomicroscopy (VLE). The decision to perform these procedures ultimately depends on if the benefit outweighs the cost and any added time performing the procedure. In our practice the added benefits of NBI and VLE outweighs the costs and added time and thus we have incorporated this into our Barrett’s surveillance routine.
